Derma Sciences (DSCI) Tops Q4 EPS by 3c

March 16, 2016 7:31 AM EDT

Derma Sciences (NASDAQ: DSCI) reported Q4 EPS of ($0.36), $0.03 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $20.3 million versus the consensus estimate of $20.21 million.

For earnings history and earnings-related data on Derma Sciences (DSCI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings